Skip to content
★ Sign in to follow
SM
Total declarations
14
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€182k

Latest filing published 28 Apr 2020 for UroGen Pharma Ltd., €3,262.

Filing timeline

BuySale
Stephen Mullennix

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

Stephen Mullennix: trading record in brief

Stephen Mullennix discloses dealings in UroGen Pharma Ltd. to SEC (Form 4). Over a trading history stretching from 14 February 2019 to 27 April 2020, the count stands at 14 filings.

Sales make up the whole of the open-market record (7 sales, €182k). Besides market trades, the filings include 7 option exercises. So far in 2020, the count stands at no purchases and 3 sales.

Most recently, on 28 April 2020, the filings show an open-market sale worth €3,262 in UroGen Pharma Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Stephen Mullennix

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total

14 of 14 declarations